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This research aims to depict the methodological steps and tools about the combined operation of
case-based reasoning (CBR) and multi-agent system (MAS) to expose the ontological application in the
ﬁeld of clinical decision support. The multi-agent architecture works for the consideration of the whole
cycle of clinical decision-making adaptable to many medical aspects such as the diagnosis, prognosis,
treatment, therapeutic monitoring of gastric cancer. In the multi-agent architecture, the ontological agent
type employs the domain knowledge to ease the extraction of similar clinical cases and provide
treatment suggestions to patients and physicians. Ontological agent is used for the extension of domain
hierarchy and the interpretation of input requests. Case-based reasoning memorizes and restores
experience data for solving similar problems, with the help of matching approach and deﬁned interfaces
of ontologies. A typical case is developed to illustrate the implementation of the knowledge acquisition
and restitution of medical experts.
 2015 Elsevier Inc. All rights reserved.1. Introduction
Medicine is a science but also a discipline of action that often
requires a decision. The complexity of decision-making, especially
in medicine and public health, comes from the uncertainty, for
example the uncertainty of knowledge, uncertainty about the facts
and the uncertainty of the language used.
A multi-agent system (MAS) for decision-aiding support uses
and combines databases, knowledge bases, ontologies, and various
modes of reasoning according to the clinical approach. The clinical
solutions emerge from the cooperation of agents specialized in
clinical stages (diagnosis, prognosis, treatment, therapeutic
monitoring) and knowledge bases developed with different
models.In the current multi-agent system [6,16], databases and com-
puter records work together to ease decision making by improving
access to relevant data through deﬁned interfaces. We focus on the
research of two types of problems with the help of case-based rea-
soning (CBR):
– Problems about classiﬁcation or diagnosis. After investigating
the uncertainty about the actual situation of the study object
(patient, organ, population), it is necessary to separate the pos-
sible symptoms and diseases from the impossible ones to deter-
mine the effective measures;
– Problem about optimization. The purpose is to point out the
most effective approach (e.g. therapeutic strategy) depending
on goal and constraints such as the physical condition of the
patient, drug contraindications, and drug secondary effect.
CBR is analogous to problem solving, which memorizes and
restores experience data to solve similar cases. To make a clinical
decision, ﬁrst of all, we generate the clinical information like
patient conditions, syndromes and medication characteristics by
information retrieval. The knowledge elements such as class (con-
cept), relation (verbs), instances (examples) and hierarchy are
combined by deﬁned interfaces and agents.
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by CBR, to provide a list of clinical suggestions to physicians. The
represented knowledge should be simple enough to be understood,
but complex enough to contain most of the problems. In this case,
the matching approach maps and extracts similar clinical cases,
then provides visual suggestions. The ontology allows us to make
use of medical knowledge base.
Several operation methods of system running are available:
semi-active method is a system with automatic trigger responding
to human intervention; active method is a system with automatic
and autonomous trigger without interfering or supervising the
decision maker. In our research, we use the passive method that
requires explicit interaction from the user to describe the problem
(e.g., the symptoms of disease, the patient’s condition, etc.) and
enquire the system. The presented system aims to provide treat-
ment advice (e.g. diagnosis, prognosis, or medication usage of sim-
ilar cases, etc.) to patients and physicians. Furthermore, all
mentioned processes are monitored and formalized by the supervi-
sor agent of multi-agents system to structure the problem and to
assess the impact of alternatives.2. Methods
2.1. Case-based reasoning
CBR is a qualitative and quantitative mixed model of experience
storage and retrieval. This method is analogous to problem solving
that compares new cases with previous indexed cases [1]. CBR
involves semantic distances developed by different approaches:
algorithms of structural similarity [10]; statistical learning as pro-
posed by [20]; digital approaches from neural networks and fuzzy
logic, etc. The researches about semantic distances tend to com-
bine symbolic and numerical aspects [2,7,15].
Fig. 1 depicts an architecture describing the CBR process. It pro-
vides two main functions: storage of new cases in the database
through case indexation module (right panel) and searching of
indexed cases by computing the components similarities of new
cases in case retrieval module (left panel).
In the case indexation module, cases are modeled as objects to
build system knowledge. All cases are stored as object cases
records.
The case retrieval module uses the database of indexed object
cases and distance to evaluate the degree of partial structural sim-
ilarity between stored cases and new cases being processed. When
a new case occurs, most similar cases are subsequently searched,
selected and adapted in the hope that the previous appropriate
treatment will be suitable for the current case [3]. This searching
function is carried out using matching approach detailed in Fig. 6.
When the case database is empty at the very beginning, we
have to input or adopt existing knowledge base systems. For
example, the online database «MedlinePlus dictionary of stomach
cancer» can be downloaded and encapsulated in CBR for the refer-
ence of relevant catalogues (e.g. 419 studies for ‘‘Stomach
Neoplasms’’ and 1667 studies for ‘‘Stomach cancer’’). The coopera-
tion features between CBR and MAS are exposed below.2.2. Multi-agent system (MAS) for clinical decision support (CDS)
MAS instantiates the Supervisor Agent Type (SAT), the General
Cognitive Agent Type (GCAT), the Knowledge Model Agent Type
(KMAT) and the Domain Speciﬁc Agent Type (DSAT) types during
two steps of specialization (Fig. 2). During the ﬁrst specialization
step, KMAT inherits the modules and features from GCAT, besides
its own speciﬁc features. For example, a rule-based KMAT has
access to an inference engine; the CBR of KMAT memorizes andrestores experience to solve similar problems, etc. An epidemiolog-
ical KMAT can reveal the incidence and prevalence of disease. The
Supervisor Agent can be instantiated to guide the decision making
process and to obtain the question answering in a reasonable time.
An SAT is a specialized agent for clinical task diagnosis (D), progno-
sis (P), treatment (H) and therapeutic monitoring (SH), as well as
a tool for knowledge retrieval with case-based reasoning (CBR) and
ontology (Ontology).
The second specialization step produces DSAT and represents
speciﬁc clinical stages D, P,H, SH (e.g. the diagnosis of infectious
disease, the prognosis depending on the overall condition of
patient, and the treatment of bacterial infection with antibiotics).
These agents use the knowledge models inherited from KMAT by
producing rules, calculating distances between knowledge objects,
using clinical case objects and statistics approaches. During each
clinical stage, all involved agents transfer queries to speciﬁc
knowledge databases for analysis and extraction. In this hybrid
approach, the autonomy of DSAT is maintained: they have the abil-
ity to accept or decline a task according to their reﬂexive
knowledge.
2.3. Medical decision process
The MAS proposed here is based on our previous work [6] and
those of other authors [14,18]. MAS is modeled using Finite State
Automata (FSA), which is a mathematical model of computation
used to design computer programs and describe simple parts of
natural languages grammars in our research. Our study deﬁnes a
modular decision-making process by standardizing clinical deci-
sion protocol and regularizing medical task (Fig. 3).
In supervised MAS (Fig. 3), we describe the community of
agents (e.g. SAT D, P, H, SH) that have been outlined in the last
section. The transactional consistency for the planning and organi-
zation of decision-making tasks is carried out through FSA, which
revolves around the decision process order of speciﬁc clinical stage
such as diagnostic (D), prognostic (P), treatment (H) and thera-
peutic monitoring (SH) (not represented to be concise) (Fig. 3).
The working memory can help to describe current situation and
collect intermediate results.
SAT CBR [6] offers an approach for retrieval and storage of
treated clinical cases, in order to build experience data corpus in
MAS. SAT CBR successively stores and indexes clinical cases and
knowledge under different directories (D, P,H, SH) by identifying
keywords about problem of case (PB), environment (patient
record) (E) and result (R).
With FSA, the supervisor monitors and triggers all necessary
steps of clinical decision process, and ensures the dialogue
between computer and ﬁnal-user. It controls the management
and execution of clinical tasks with predeﬁned available agents.
An agent is instructed to give up a task if the situation or operating
environment is amended (e.g. the output of MAS is assumed by the
user; the query has expired, etc.).
The models of knowledge (Fig. 2) are encapsulated in the agents
detailed in Fig. 3. Each agent uses its reﬂexive knowledge to deter-
mine whether it should contribute in the task requested by the
supervisor. The degree of specialization, the nature of the task,
the knowledge available in the database, and the mode of reason-
ing are involved in this choice. If the agent accepts, the supervisor
takes part into the on-going actions, and then the necessary agents
become active. The answers are extracted and listed from MAS
through matching approach by consulting the working memory
and similar clinical cases, and by requesting information through
the user interface.
MAS dialog user interface (Fig. 4) sums up results within an
acceptable time. Overloading of supervisor interfaces and rela-
tively low autonomy of agents are negative aspects. According to
Fig. 1. Case-based reasoning.
Fig. 2. Specialization of agents involved in a multi-agent system for clinical decision support [6].
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lowing classes: diagnosis, prognosis, treatment, and therapeutic
monitoring (Fig. 4) [17]. Blue lines and arrows indicate data ﬂow
between classes, while red1 arrows point to data transfers between
classes.
There are four different types of diagnoses. After conﬁrming the
type of diagnosis (e.g. etiological diagnosis, unknown diagnosis,
positive diagnosis and differential diagnosis), the class
«Prognosis» transfers the results of prognosis to the class
«Treatment». The class «AdministrationSchema» monitors the
classes «Medication» and «SurgicalProcedure». With the diagnosis
and prognosis of the involved case, as well as the treatment1 For interpretation of color in Fig. 4, the reader is referred to the web version of
this article.adopted, we can establish the patient’s record that, in return,
may provide new information to different classes.
2.4. Medical information retrieval
To explain the steps of decision-making and the operation of
deﬁned ontological interfaces, the gastric cancer is taken as an
example. For the diagnosis, prognosis and treatment of gastric can-
cer, we combine several medical specialties to determine rational
treatments including surgery, chemotherapy, radiation therapy
and targeted therapy. As appropriate, the objectives are: cure
(completely eradicate cancer cells) or control tumor, extending
the life of patient and improve physical condition, personal and
social life.
The indexed corpus data such as patient (ID, History, Condition),
diagnosis (Syndrome, Cause), prognosis (Effect, Signs, Time),
Fig. 3. Supervisor agent, general clinical FSA agent, and FSA speciﬁc D, P, H and CBR agent.
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Fig. 4. Relations and interactions between classes «diagnostic (D)», «prognostic (P)», «treatment (H)» and «therapeutic monitoring (SH)».
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and therapeutic monitoring (Record) can be accessible through the
deﬁned interfaces (e.g. hasID, hasHistory,
hasAdministrationSchema...) which have been detailed in Fig. 4.
To obtain the result of optimal medication, we need to take into
account patient condition (MedicationAllergy) and medication
characters such as DrugContraIndication, DrugSideEffect,
DrugInteractions, medication compatible, and prescription accord-
ing to potential risk of side effects. After considering the age, the
physical condition and the coexisting disease of patient, the CBR
searches the medications and surgical procedures from similar
cases stored in corpus with the help of language analysis and
matching approach (Fig. 6). The language analysis in the ﬁeld of
nature language processing is based on our previous work [17],
aiming to represent stemming and synonyms (e.g. stomach cancer:
gastric cancer, gastric carcinoma. . .) of target words, with the help
of existing dictionaries (e.g. Larousse, Littré and Robert for French
language) and deﬁned algorithms described in previous articles.
During matching approach, the matching algorithm is launched
to verify whether corresponding contents exist in the MAS. If yes,
clinical cases with the relevant concepts, synonyms or relations
are extracted for question answering. The result depends on the
content of knowledge base.
The Supervisor Agent monitors the optimal surgical procedure.
After verifying the contraindications between Surgical Procedureand Medications, the optimal personalized treatment is presented
with some details such as prescribed specialty (contraindication
related to the administration route), daily cost of treatment, exis-
tence of a generic, and participants of surgical procedure.3. Results: example to illustrate the operation of CBR
3.1. Ontological agent type
With the deﬁned classes and relations shown in Fig. 4, we use
UML (Uniﬁed Modeling Language) notation to express semantic
relations deﬁning the terminologies of domain knowledge. These
initial ontologies of gastric cancer are established manually with
elementary knowledge collected from clinical medical dictionaries.
These ontological models are based on the semantic comprehen-
siveness of object-oriented models. They are the basis of ontologi-
cal extension.
Fig. 7.1 shows the classiﬁcation of treatment procedure agents,
corresponding to the variable TreatmentType of «SurgicalProcedu
re» class deﬁned in Fig. 4. In Fig. 7.2, the «Syndrome» and
«Signes» classes encapsulated in Fig. 4 carry out the description
of disease as a series of medical conditions including pathog-
nomonic, compulsory evocative or accessories clinical signs related
to pathology. The ontology of Fig. 7.3 describes the medication
Fig. 5. Decision-making processes – search the optimal medications and surgical procedures.
Fig. 6. Matching approach for similar cases extraction through language analysis and MAS operation.
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the variable MedicationType of «Syndrome» class shown in Fig. 4.
Fig. 7.4 expresses the fact that, in light of patient condition of
«Diagnosis» class (Fig. 4), targeted therapy and chemotherapy can
be employed to reduce or eradicate cancer cells that cause gastric
cancer. Fig. 7.1–7.4 shows that a class diagram of UML provides
adequate semantic and graphic capabilities to encode ontology.
The ontological agent type creates a single instance of ontological
agent in knowledge domain and provides common terminology to
all specialized agents, e.g. diagnosis of infectious diseases, antibi-
otics prescription, etc. Ontologies are conceptual collective sym-
bolic representations which are based on interactions between
specialized agents contributing to the development of common
solution about the problem posed by each clinical stage.3.2. Diagnosis, prognosis and treatment of gastric cancer
Tables 1.1–1.4 illustrates the diagnosis, prognosis and treat-
ment of gastric cancer. These clinical activities are supervised by
the MAS and carried out by CBR.The SAT D is about the diagnosis of gastric cancer (Table 1.1).
The inference graph (Table 1.2) is established manually by refer-
encing to the evolution process of existing gastric cancer cases, cor-
responding to the structure of SAT D presented in Fig. 3. In this
inference graph, D0 indicates a positive diagnosis, while D1 spec-
iﬁes a differential diagnosis and D2 to 6 identify etiological diag-
noses. The initial presence of gastric cancer (SO1) can lead to
diagnostics D1 to D6 according to clinical evocative signs SE1 to
SE6.
The SAT P presents related prognosis (P1 to P6) according to
the SAT D (Table 1.4). With the knowledge of surgical procedure
PC1 to PC6 (Table 1.3), SATH indicates various therapeutic strate-
gies (H1 to H6) (Table 1.4) corresponding to different diagnostics
and prognostics. For the sake of brevity, the therapeutic monitor-
ing SH is not exposed in this article. The knowledge encapsulated
in these several steps is stored in MAS and can be extracted by CBR
and matching approach.
Table 2 develops a result of similar clinical cases extraction.
Patients or physicians input the patient’s condition through the
users interfaces (Fig. 3). Simultaneously, the patient’s history is
extracted from patient records (Fig. 4). These combined materials
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Fig. 7. Ontology agent type about gastric cancer represented by UMLS class diagrams.
Table 1.1
Legend of clinical obligatory signs (SO), and evocative signs (SE).
SO1 The tumor grows in the lamina propria, muscularis mucosa, or the
submucosa (inner layers of the stomach wall)
SE1 No evidence of lymph node metastases
SE3 The tumor grows in the muscularis (muscle layer of the stomach)
SE4 The tumor grows through all the layers of muscle in the connective
tissue on the outside of the stomach, but not in the propagation of
serous or peritoneal wall
SE5 The tumor grows through all the layers of muscle in the connective
tissue outside the stomach and develops into the peritoneum or serous
or organs surrounding the stomach
SE6 Recurrent cancer after treatment. Probably a localized recurrence
(return to where it started), or may be a distant metastasis (back in
another part of the body)
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presented example, the CBR base of object cases serves as a corpus,
to search optimal treatments for a 40-year-old man with gastric
cancer at the postoperative IIIa stage and pyloric obstruction.
After splitting up this new clinical case and its corresponding
health record, CBR computes its component similarities by explor-
ing indexed knowledge. The matching approach (Fig. 6) is launchedto carry out the knowledge representation and similar clinical
cases selections. CBR seeks to identify the clinical case with impor-
tant words such as terminologies (e.g. syndrome: acid reﬂux,
belching, vomiting. . .) and their synonyms, as well as adjectives
(e.g. upper abdominal discomfort, occasional postprandial pain. . .)
and verbs (occur, accompany, cause. . .) that make phrase more
precise.
In Table 2, with the information of current patient such as D
(gastric cancer stage IIIa) and PB (problem of current case:
high-differentiated adenocarcinoma, pyloric obstruction, palpable
mass, abnormal thickening of antral wall and mucosa. . .), MAS
works with CBR to search and provide a list of clinical treatment
suggestions to patients and physicians.
Afterward, with the help of application object ﬁltering and
deﬁned ontological interfaces from Fig. 5, MAS ﬁlters out the
unnecessary treatment suggestions by taking into account some
elements such as medication allergy, medication side effect, coex-
isting disease, and complication.
Concerning the case provided at the top of Table 2 (clinical case
in need of help), 17 relevant cases are extracted from CBR corpus as
treatment suggestions. All these similar clinical cases are listed by
MAS in reverse order according to their word matching numbers.
Table 1.2
Diagnosis and prognosis of gastric cancer.
Table 1.3
Legend of surgical procedure (PC).
PC1 Surgery: the laparotomy can check whether palliative resection is
operable. Otherwise, the jejunostomy allows nutritional support.
During Stage 4 of gastric cancer, surgery cannot be performed
PC2 Palliative chemotherapy: applies after the patient had recurrent or
palliative resection, or apply to the patient on whom palliative
resection is not operable but the whole body is in good condition and
the function of major organs are normal
PC3 Adjuvant chemotherapy: adjuvant chemotherapy is intended to increase
or boost the positive effects of other forms of treatment, such as surgery
or radiotherapy. Object of treatment Includes: patients at the Stage 1b
of pathological postoperative with lymph node metastases; patients in
Stage 2 and after the pathological postoperative
PC4 Neoadjuvant chemotherapy: a neo-adjuvant treatment is administered a
pretreatment to reduce the size of a cancerous tumor (malignant)
before surgery (and therefore limited resection) or radiotherapy
(increase efﬁciency). It is suitable for patients in the Stage 3 and Stage 4
PC5 Radiation therapy: radiation therapy is a method of locoregional
treatment of cancer using radiation to destroy cancer cells by blocking
their ability to multiply. It can be used alone or in combination with
surgery and chemotherapy. Its indications are related to the type of
tumor, its location, its stage and condition of the patient
PC6 Targeted therapy: molecular targets are essentially receptor epithelial
growth factor (EGFR), vascular endothelial growth factor (VEGFR),
receptor human epidermal growth factor-2 (HER-2), etc.
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panel) is detailed in this article with key elements:
– 1st round H: underwent radical gastrectomy;
2nd round H: laparotomy + retroperitoneal partial resec-
tion + abdominal tumor reduction surgery
3rd round H: chemotherapy: CPT-11(120 mg) + 5-Fu(300 mg);
4th round H: nodular partial excision + side-by-side
ascending-ilea colon.Table 1.4
Diagnosis, prognosis and treatment of gastric cancer.
Diagnostics Prognostics
D0 Gastric cancer
D1 Early stage gastric cancer
without evidence of lymph
node metastases
P1 About 90% of patients have 5-yea
survival after the resection of ear
gastric cancer.
D2 Gastric cancer with lymph
node metastases
P2
D3 Advanced locally gastric
cancer
P3 Relieve symptoms
D4D5 Advanced unresectable
gastric cancer
P4P5 Complete response (CR) rate is le
than 30%, the median survival tim
is from 6 to 12 months
D6 Recurrent or metastatic
gastric cancer
P6 Relieve symptoms– 1st round SH: postoperatively adjuvant chemotherapy;
2nd round SH: intraperitoneal chemotherapy with DDP 2;
4th round SH: chemotherapy with DDP + 5-FU.
And R (result: death; survival time: 4 years 11 months), as well
as some additional information like date and duration.
Other 16 extracted similar cases are not detailed for the sake of
brevity. Physicians can therefore make clinical decisions by refer-
encing to similar cases provided by MAS.
Classes (predeﬁned in Fig. 7.1–7.4 and used in Tables 1.1–1.4),
as well as relations and interactions (detailed in Fig. 4) employed
in the gastric cancer example, are depicted in Fig. 8: a patient
involves the phrase of diagnosis, prognosis, treatment and
therapeutic monitoring. The compulsory and evocative clinical
signs lead to different prognosis (P1 to P6). The knowledge
bases of CBR provide a list of optimal medication and surgical pro-
cedure to multi-agents system and physician by searching similar
clinical cases and ﬁltering out unsuitable treatments (Fig. 5). After
renewing the patient record, the «AdministrationSchema» agent
monitors all phrases of treatments, and perhaps changes the
therapeutic programs according to the patient’s condition. In case
of tumor recurrence, a new cycle of medical procedure will be
launched.
This visual ﬁgure (Fig. 8) indicates the tasks and data ﬂow
between different agents. All operations are carried out through
the interfaces triggered by MAS.
To evaluate the proposed CDS, domain experts are involved to
provide feedback on accuracy. After ensuring the accuracy of data
sources and formulating treatment rules (Tables 1.3 and 1.4), clin-
icians check the extraction results (diagnosis, prognosis and treat-
ment) and carry out appropriate adjustments according to their
clinical knowledge.
In order to evaluate the performance of MAS operated with CBR,
we propose a methodology based on [4,8]. The extraction of clinical
case suggestion is measured in terms of efﬁciency by weighted
average formula shown below, where K is the number of keyword
matched, C is the number of words in new inputted health record,
which seeks suggestion from similar clinical cases.
Pn
i¼1
Pp
j¼1Kij
 
Pn;p
i;j¼1;1j Ci
Considering gastric cancer as example, 17 relevant cases are
extracted from CBR corpus with different word matching numbers
(e.g. 39 matching words in the example; while 46, 42, 40, 37, 33,
30, 29, 23, 22, 19, 16, 14, 13, 8, 7 and 4 matching words in otherTherapy
r
ly
H1 PC1 Endoscopic therapy or surgery without adjuvant radiotherapy
or chemotherapy postoperatively
H2 PC1 + PC3 Curative surgical excision depending on the depth of
tumor invasion. According to the circumstances, radical surgery
may be performed directly or after the neoadjuvant
chemotherapy
H3 PC3 + PC4 Adopt combination therapy based on surgery. After the
successful implementation of radical surgery, one must decide
assisted therapy program according to the stage of disease
(adjuvant chemotherapy, adjuvant radiotherapy...)
ss
e
H4H5 PC2 With palliative chemotherapy based on 5-FU, the main
objective is to relieve symptoms caused by the cancer, such
vomiting, ascites, distension, and abdominal pain
H6 PC2 + PC5 + PC6 Adopt combination therapy based on medication
treatments and surgical treatments such as palliative surgery,
radiotherapy, interventional therapy, and radiofrequency ablation
Table 2
Extraction of similar clinical cases using CBR.
Clinical case in need of help
40-year-old man with gastric cancer stage IIIa and pyloric obstruction (coexisting disease). In January, upper abdominal discomfort occurs, accompanied by acid reﬂux,
belching, occasional postprandial pain. No vomiting and other symptoms. May 15 morning vomiting, sore throat. A diameter of 4 cm palpable mass in the right
upper pressure sensitive quadrant
On June 12, pathology reports (antrum) high-differentiated adenocarcinoma. Reports CT (abdomen + pelvic ultrasound + strengthened + gastric reconstruction):
abnormal thickening of antral wall and mucosa; In relation to disease of the gallbladder; Side of the pylorus and lesser curvature, presence of several lymph nodes;
thickening of the wall of the bladder, prostate hypertrophy growth; initial segment of celiac corrugated under pressure. Light luminal stenosis, can be caused by
compression of the ligament of the plantar arch
Clinical case suggestion no. 1
A 62-year-old man with gastric cancer at the postoperative IIIa stage and pyloric obstruction. He had a history of hypertension. He is in good health and his family history
is negative
March 2001, underwent radical gastrectomy. Pathology reports: adenocarcinoma stage II–III involving the whole layer, 2/20 lymph node metastases. Operate 8 cycles of
postoperatively adjuvant chemotherapy. [Taxol(85 mg/m2) + CF(400 mg/m2) + 5-Fu(0.5 g) + 5-Fu(3.0 g/m2) (repeated every 2 weeks)] Patients with signiﬁcant
peripheral nerve toxicity, and other lighter side effects
December 2002 (21 months after operation) abdominal pain (CA19-9 >5000 ng/L). PET-CT: soft tissue of the sub-capsular in the right lobe thickened, supra-umbilical
nodular soft tissue appear shade and have a high metabolic.
January 2003, Treatment = Laparotomy + Retroperitoneal partial resection + Abdominal tumor reduction surgery. A large granular mass is found in the peritoneum and
diaphragm, the largest is 4 ⁄ 5 cm. Postoperative: intraperitoneal chemotherapy with DDP 2 times; Systemic chemotherapy: Docetaxel(60 mg) + Xeloda(1500 mg) (4
cycles, repeated every 3 weeks). Evaluation: preoperative: CA19-9 5029 U/ml; After 4 cycles of chemotherapy: 233.9 U/ml. The reasons for the interruption of
chemotherapy: during the ﬁfth cycle of chemotherapy, he has the adhesive incomplete bowel obstruction, therefore stop the chemotherapy
February 2004 (12 months after intraperitoneal chemotherapy) CA19-9 signiﬁcantly increased. CT: metastasis in the liver, the lungs and the abdominal cavity
March–September 2004, Chemotherapy: CPT-11(120 mg) + 5-Fu(300 mg) (4 cycles, 4 consecutive weeks, stop two weeks, repeat every 6 weeks). CA19-9 decreased to
the normal range. The metastatic liver and lung shrink
December 2005. Readmission for incomplete intestinal obstruction, and liver metastases, abdominal pelvic and lungs are expanded. Laparotomy shows that there are
different sizes of the blanks in abdominopelvic tumor nodules, and portions of the small intestine adherent to each other. Treatment = nodular partial
excision + side-by-side ascending-ilea colon. Postoperative = DDP + 5-FU chemotherapy 2 times
February 2006. Obstruction of the small intestine, massive ascites, bloody stools, difﬁculty in breathing, give up rescue, death
Clinical case suggestion no. 2
...
Clinical case suggestion no. 17
...
Fig. 8. Ontology used for diagnosis, prognosis and treatment of gastric cancer.
Y. Shen et al. / Journal of Biomedical Informatics 56 (2015) 307–317 315extracted cases respectively.) Therefore, the matching rate of
extraction is 20.5%, while n equals 17; C equals 121; j ⁄ Ci equals
121 ⁄ 17; (K)i = (46, 42, . . ., 4).Besides the provided example, there are 6 diseases or biological
processes that were investigated for testing, including breast can-
cer, acute diarrhea, addiction, antibiotics and infectious diseases,
316 Y. Shen et al. / Journal of Biomedical Informatics 56 (2015) 307–317etc. For illnesses without variant complications or complex syn-
dromes like acute diarrhea, the matching rate reaches 78.2%
according to our previous studies [17].4. Discussion
Decision support is a probabilistic and quantitative method
intended to problems modeling in situations of uncertainty. The
results obtained in previous sections have highlighted the neces-
sity of the cooperation between MAS and CBR.
The application of multi-agent systems for the cooperation of
knowledge bases is not a new research subject but has been inves-
tigated in many works shown below. The article [9] develops the
concept of self-healing systems. As systems increase in complexity,
rectiﬁcation of system faults and recovery from malicious attacks
become more difﬁcult, labor-intensive, and error-prone. These sys-
tems employ models, either external or internal, to monitor system
behavior and use inputs obtained therefore to adapt themselves to
the run-time environment. Model structure and system construc-
tion are a useful reference to our research.
The work [13] exposes an approach for monitoring and diagno-
sis of multi-agent systems where mobile robotic agents provide
services and partial observability of the environment is achieved
via a set of ﬁxed sensors. However, this kind of systems exhibits
complex dynamics where weak predictable interactions among
agents may arise.
SAPHIRE [12] is a macroscopic system capable of interoperabil-
ity of devices, databases and knowledge. It is based on clinical
guidelines and ontological agents, but not guided by clinical
approach model. Therefore, it cannot deal with complex medical
cases.
Many other studies also develop the design and the implemen-
tation of MAS in the ﬁeld of healthcare, emphasizing its functional
model and architecture, to carry out the treatment of chronic dis-
ease [11], evaluating the health of diets [19], etc.
The MAS proposed in this article ensures the cooperation of
heterogeneous medical knowledge bases. It is based on clinical
approach and a set of our work over the last thirty years
[5,6,16,17]. It offers an interactive approach to users via the super-
visor agent, and ensures the interoperability of data models and
knowledge encapsulated in the agents. The semantic interoperabil-
ity of knowledge is provided by ontologies agents. The implemen-
tation of multi-agent system and its agent types are to deﬁne rules
and interfaces for the knowledge representation and request
answering.
In terms of weaknesses of this study, we acknowledge that the
presented approach of knowledge representation has difﬁculties to
analyse and extract evolutionary contexts that are constantly
renewed. The problems related to recursion and complexity of
knowledge lead to the acceptance of incompleteness of the pro-
posed models, including the inability to access a completely auto-
mated production of ontologies except in very simple ﬁelds, if any.
With the proposed method, it seems interesting to study Big
Data to enlarge the scope of the research of clinical decision sup-
port with electronic health records (EHRs) and electronic quality
measures (eQM). The automatic generation of EHRs is carried out
using images, pharmacy records or clinical notes by combining
health, ﬁnancial and research data through data mining. The reli-
able EHRs can improve the accuracy of similar clinical cases map-
ping and extraction (Tables 1.1–1.4 and Table 2). The eQM can be
adopted to measure the MAS operation by evaluating the informa-
tion exchange in order to improve the clinical quality and safety.
Currently, eQM remains manual in our studies. The relation
between health staff and patient is an approach that we want to
deepen in the future.5. Conclusion
This article presents a research about clinical information
retrieval from medical knowledgebase to carry out the question
answering between MAS and ﬁnal users with the help of CBR.
This study tries to improve the acquisition of accessible knowledge
from the clinical processes, and reduce the abundance of inappro-
priate quotations of existing medical databases, which require a
tedious sorting process incompatible with the medical practice.
The approaches and methods adapted to information process-
ing and decision-making are based on the specialization of agents
suitable for clinical knowledge models. Specialized agents ensure
the interoperability and cooperation of encapsulated knowledge
bases.
The rest of our contribution is to illustrate the use of CBR
adapted to search optimal medication or treatment from similar
clinical cases, to improve the knowledge representation and the
generation of medical ontologies at each stage of the clinical pro-
cess. The approach combining MAS and CBR can support formal
reasoning of medicine and related ﬁelds.Conﬂict of interest
The authors declare that there have no conﬂict of interest.
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